Urea derivatives and their use as integrin inhibitors
CA 2308716 A1 · Owner: Brittain, David Robert · Inventors: Brittain, David Robert; Johnstone, Craig
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Compounds of formula (II) where R1 is in the para or meta position and is (A); R2 and R3 are each independently selected from hydrogen nitro, C1-6alkyl, C3-, 6cycloalkyl, C2-6alkenyl C2-6alkynyl, C1-4alkoxyl, C1-6alkylamino C1-, 6dialkylamino, C1-6alkylC1-4alkoxyl C1-6alkylaminoC1-6alkyl, amino, cyano, halogeno trifluoromethyl, -CO2R12 and -CONR12R13 where R12 and R13 are , independently selected from hydrogen or C1-6alkyl or R2 and R3 together with , the phenyl to which they are attached form a 9 or 10 membered bicyclic ring system; R4 is C1-4alkyl; R5 is selected from hydrogen and C1-4alkyl; R6 is selected from C1-6alkyl, C1-4alkyl(C4-6)cycloalkyl C1-6alkyl(C1-6)alkoxyl, C1-, …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 9, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 9, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 9, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.